Stocks of Oscar Health Inc (NYSE:OSCR) traded higher last session on Wall Street, down -3.88% to $15.62.
OSCR stock price is now 3.65% away from the 50-day moving average and -8.32% away from the 200-day moving average. The market capitalization of the company currently stands at $3.91B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $12, Jefferies recently initiated with Underperform rating for Oscar Health Inc (NYSE: OSCR). On November 06, 2024, BofA Securities Downgraded its previous ‘Neutral’ rating to ‘Underperform’ on the stock reducing its target price from $21 to quote $13.50, while ‘UBS’ rates the stock as ‘Neutral’
In other news, ALESSANDREA QUANE, Officer bought 20,000 shares of the company’s stock on Mar 05 ’25. The stock was bought for $325,654 at an average price of $16.28. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 04 ’25, Former Affiliate STEVEN WOLIN bought 167,466 shares of the business’s stock. A total of $2,519,576 was incurred on buying the stock at an average price of $15.05. A total of 29.63% of the company’s stock is owned by insiders.
During the past 12 months, Oscar Health Inc has had a low of $12.43 and a high of $23.79.
The net profit margin was 0.28% and return on equity was 2.80% for OSCR. The company reported revenue of $2.39 billion for the quarter, compared to $1.43 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 67.11 percent.
